# Neurology Phase 4A report

## Scope

This checkpoint covers the Neurology validation/audit infrastructure plus the
cerebrovascular and seizures/epilepsy manifests. Renal was not started.

## Truthful audit results

- All 13 manifests are nonempty, parse as YAML, and contain 176 explicit disease entries.
- The scoped vascular/seizure modules have 0 detected relationship-template hits.
- The whole Neurology corpus still has 2,430 relationship-template hits in later Phase 4 modules; they remain explicitly reported rather than suppressed.
- Shared algorithm audit found 0 padded contingency nodes and 0 decision nodes whose true and false paths silently converge.
- Generated relationships in the Phase 4A scope remain `unverified_ai_generated` pending topic-specific references.
- Every P1/P2 vascular or seizure/epilepsy disease now has at least one owned finding and one keyword; the scoped duplicate-ID and source-status validators pass.

## Phase 4A content changes

- Converted the JSON-formatted `.yaml` files into genuine YAML.
- Added explicit vascular illness scripts for stroke, hemorrhage, CVST, cervical dissection, RCVS, PRES, traumatic hemorrhage, vascular cognitive disease, and vascular localization syndromes.
- Added explicit seizure illness scripts and reassigned syndrome-specific clue ownership: three-hertz spike-and-wave, hypsarrhythmia, morning myoclonus, temporal-lobe aura/automatisms, slow spike-and-wave, and prolonged febrile seizures in infancy.
- Replaced artificial algorithm padding and generic unsafe nodes with divergent false paths.
- Added 12 Phase 4A field-level semantic assertions; the suite now contains 47 passing tests.

## Next module

The 4A.1 acceptance gate is satisfied, so Phase 4B may proceed with the next
Neurology module (headache, infections, and demyelinating disease), not Renal.
